Evidence map›Paper›PMID 39625409›Full record

ReviewJournal of extracellular vesicles2024

Extracellular vesicles, RNA sequencing, and bioinformatic analyses: Challenges, solutions, and recommendations.

Rebecca T Miceli, Tzu-Yi Chen, Yohei Nose, Swapnil Tichkule, Briana Brown, John F Fullard, Marilyn D Saulsbury, Simon O Heyliger, Sacha Gnjatic, Natasha Kyprianou and 7 more

Abstract readReview
In one paragraph

Review in Journal of extracellular vesicles, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Rebecca T MiceliDepartment of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Tzu-Yi ChenDepartment of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Yohei NoseDepartment of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Swapnil TichkuleDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Briana BrownDepartment of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
John F FullardDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Marilyn D SaulsburyDepartment of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, Virginia, USA.
Simon O HeyligerDepartment of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, Virginia, USA.
Sacha GnjaticDepartment of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Natasha KyprianouDepartment of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Carlos Cordon-CardoDepartment of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Susmita SahooDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0002-7279-1564
Emanuela TaioliDepartment of Population Health and Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Panos RoussosDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Gustavo StolovitzkyDepartment of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Edgar Gonzalez-KozlovaDepartment of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Navneet DograDepartment of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0002-4602-3991

Funding

THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ramon E Parsons · 2015 to 2026
$35.4M
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy TrialsU24CA224319 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Sacha Gnjatic, Seunghee Kim-Schulze · 2017 to 2026
$21.5M
Extracellular Vesicle-Encapsulated AAVs for Therapeutic Gene Delivery to the HeartR01HL148786 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Kiyotake Ishikawa, Susmita Sahoo · 2019 to 2026
$4.1M
Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesisR01DK133885 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI KENT, SALLY CHOATE, REIJONEN, HELENA KRISTIINA · 2022 to 2025
$3.0M
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patientsU01DK124165 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI COLOMBEL, JEAN-FREDERIC, FAITH, JEREMIAH JAMES · 2020 to 2024
$2.9M
Disparities in molecular testing among non-small cell lung cancer patientsP20CA264076 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TAIOLI, EMANUELA · 2021 to 2024
$1.2M
Delineating the RNA cargo of exosomes from brain microenvironmentR21AG078848 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DOGRA, NAVNEET · 2022 to 2022
$464k
Navneet Dogra NIH P20CA264076Navneet Dogra NIH R21 AGO78848NCI NIH HHS P20 CA264076NCI NIH HHS P30 CA196521NCI NIH HHS U24 CA224319NHLBI NIH HHS R01 HL148786NIA NIH HHS R21 AG078848NIDDK NIH HHS R01 DK133885NIDDK NIH HHS U01 DK124165Sacha Gnjatic CA196521Sacha Gnjatic CA224319Sacha Gnjatic DK124165S.O.H., M.D.S., E.T. NIHP20CA264076Susmita Sahoo Evox TherapeSusmita Sahoo NIH R01DK133885Susmita Sahoo NIH R01HL148786
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are heterogeneous entities secreted by cells into their microenvironment and systemic circulation. Circulating EVs carry functional small RNAs and other molecular footprints from their cell of origin, and thus have evident applications in liquid biopsy, therapeutics, and intercellular communication. Yet, the complete transcriptomic landscape of EVs is poorly characterized due to critical limitations including variable protocols used for EV-RNA extraction, quality control, cDNA library preparation, sequencing technologies, and bioinformatic analyses. Consequently, there is a gap in knowledge and the need for a standardized approach in delineating EV-RNAs. Here, we address these gaps by describing the following points by (1) focusing on the large canopy of the EVs and particles (EVPs), which includes, but not limited to - exosomes and other large and small EVs, lipoproteins, exomeres/supermeres, mitochondrial-derived vesicles, RNA binding proteins, and cell-free DNA/RNA/proteins; (2) examining the potential functional roles and biogenesis of EVPs; (3) discussing various transcriptomic methods and technologies used in uncovering the cargoes of EVPs; (4) presenting a comprehensive list of RNA subtypes reported in EVPs; (5) describing different EV-RNA databases and resources specific to EV-RNA species; (6) reviewing established bioinformatics pipelines and novel strategies for reproducible EV transcriptomics analyses; (7) emphasizing the significant need for a gold standard approach in identifying EV-RNAs across studies; (8) and finally, we highlight current challenges, discuss possible solutions, and present recommendations for robust and reproducible analyses of EVP-associated small RNAs. Overall, we seek to provide clarity on the transcriptomics landscape, sequencing technologies, and bioinformatic analyses of EVP-RNAs. Detailed portrayal of the current state of EVP transcriptomics will lead to a better understanding of how the RNA cargo of EVPs can be used in modern and targeted diagnostics and therapeutics. For the inclusion of different particles discussed in this article, we use the terms large/small EVs, non-vesicular extracellular particles (NVEPs), EPs and EVPs as defined in MISEV guidelines by the International Society of Extracellular Vesicles (ISEV).

Indexed as

Computational BiologyExtracellular VesiclesSequence Analysis, RNAExosomesHumansRNATranscriptomeRNAbioinformaticsEVsextracellular vesicleslong‐read sequencingshort‐read sequencingsmall RNAtranscriptomics

Identifiers

PMID39625409
PMCPMC11613500

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.